Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Dow
Express Scripts
Teva
Accenture
Farmers Insurance
Queensland Health
Argus Health
Covington
Boehringer Ingelheim

Generated: August 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208025

« Back to Dashboard
NDA 208025 describes LANSOPRAZOLE, which is a drug marketed by Labs Liconsa, Natco Pharma Ltd, Sun Pharm Inds Ltd, Krka Tovarna Zdravil, Perrigo R And D, Dexcel Pharma, Wockhardt Ltd, Ani Pharms Inc, Sandoz, Teva Pharms, Ajanta Pharma Ltd, Mylan Pharms Inc, Zydus Hlthcare, Dr Reddys Labs Ltd, Wockhardt Usa, Rising Pharms Inc, Teva Pharms Usa, and Sandoz Inc, and is included in twenty-two NDAs. It is available from eighty-two suppliers. Additional details are available on the LANSOPRAZOLE profile page.

The generic ingredient in LANSOPRAZOLE is amoxicillin; clarithromycin; lansoprazole. There are forty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.

Summary for NDA: 208025

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 208025

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LANSOPRAZOLE
lansoprazole
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 208025 NDA Walgreen Company 0363-1419 0363-1419-55 42 BLISTER PACK in 1 CARTON (0363-1419-55) > 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
LANSOPRAZOLE
lansoprazole
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 208025 NDA Walgreen Company 0363-1419 0363-1419-74 14 BLISTER PACK in 1 CARTON (0363-1419-74) > 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORALStrength15MG
Approval Date:Jun 7, 2016TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Accenture
Merck
Cantor Fitzgerald
Cipla
Novartis
Johnson and Johnson
Daiichi Sankyo
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot